Infections and human tissue transplants: Review of FDA MedWatch reports 2001-2004

Cell and Tissue Banking

Volumn 8, Issue 3, 2007, Pages 211-219

  Wang, Su ^a   Zinderman, Craig ^a   Wise, Robert ^a   Braun, Miles ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Advere events; Allograft associated infections; Allografts; Infections; Regulation; Surveillance; United States

Indexed keywords

ANTIBIOTIC AGENT;

AGE DISTRIBUTION; ALLOTRANSPLANTATION; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BLOOD VESSEL; BONE; CONSUMER; DEMOGRAPHY; EYE; GOOD CLINICAL PRACTICE; HEART VALVE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; MORTALITY; MYCOSIS; NURSE; OPERATING ROOM PERSONNEL; OUTCOMES RESEARCH; PATIENT SAFETY; PHYSICIAN; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PRION DISEASE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK MANAGEMENT; SKIN; TENDON; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; DISEASE NOTIFICATION; HUMANS; INFANT; INFANT, NEWBORN; INFECTION; MIDDLE AGED; TIME FACTORS; TISSUE TRANSPLANTATION; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34547625448     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-007-9034-3     Document Type: Review

References (22)

1. American Association of Tissue Banks (2004) Annual Tissue Bank Survey. American Association of Tissue Banks, Mclean, Virginia
2. American Association of Tissue Banks (2003) Annual Tissue Bank Survey. American Association of Tissue Banks, Mclean, Virginia
3. Centers for Disease Control, Prevention (1988) Epidemiologic notes and reports transmission of HIV through bone transplantation: Case report and public health recommendations MMWR 37(39):597-599. http://www.wonder.cdc.gov/wonder/prevguid/m0001284/m0001284.asp
4. Centers for Disease Control and Prevention (2001) Septic arthritis following anterior cruciate ligament reconstruction using tendon allografts - Florida and Louisiana, 2000. MMWR: 001:50(48):1081-1083. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5048a3.htm
5. Centers for Disease Control and Prevention (2002) Update: allograft-associated bacterial infections - United States, 2002. MMWR: 51(10):207-210. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5110a2.htm
6. Centers for Disease Control and Prevention (2003a) Invasive Streptococcus pyogenes after allograft implantation - Colorado, 2003. MMWR: 52:1173-1176
7. Centers for Disease Control and Prevention (2003b) Hepatitis C virus transmission from an antibody-negative organ and tissue donor - United States, 2000-2002. MMWR: 52(13):273-276 http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5213a2.htm
8. Chen RT, Rastogi SC, Mullen JR, Hayes S, Cochi SL, Donlon JA, Wassilak SG (1994) The vaccine adverse event reporting system (VAERS). Vaccine 12:542-550
9. Eastlund T, Strong DM (2003) Infectious disease transmission through tissue transplantation. In: Phillips GO (ed), Advances in tissue banking, vol 7. World Scientific Publishing Company, Singapore, pp 51-131
10. Food and Drug Administration (2004a) Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products; final rule and notice. 21 CFR Part 1271. Federal Register 69 (May 25):29785-29834
11. Food and Drug Administration (2004b) Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement; Final Rule. 21 CFR Part 1271. Federal Register 69(November 11):68611-68688 http://www.access.gpo.gov/nara/cfr/waisidx_05/21cfr1271_05.html
12. Food and Drug Administration (2005) Procedures for handling adverse reaction reports related to "361" human cells, tissues, and cellular and tissue-based products (HCT/Ps). http://www.fda.gov/cber/ regsopp/8508.htm
13. Joint Commission on Accreditation of Healthcare Organizations (2005) Standards for tissue storage and issuance: PC.17.10, PC.17.20, PC.17.30. Oakbrook Terrace, IL; Joint Commission on Accreditation of Healthcare Organizations; 2005. Available at: http://www.jcrinc.com/subscribers/ perspectives.asp?durki=9160&site=10&return=6065
14. Kainer MA, Linden JV, Whaley DN, Homes HT, Jarvis WR, Jernigan DB, Archibald LK (2004) Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 350:2564-2571
15. Kessler DA (1993) Introducing MedWatch: A new approach to reporting medication and device adverse effects and product problems. JAMA 269:2765-2768
16. Keyhani K, Seedor JA, Shah MK, Terraciano AJ, Ritterband DC (2005) The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty. Cornea 24(3):288-291
17. Kuehnert MJ, Clark E, Lockhart SR, Soll DR, Chia J, Jarvis WR (1998) Candida albicans endocarditis associated with a contaminated aortic valve allograft: Implications for regulation of allograft processing. Clin Infect Dis 27(4):688-691
18. Lang CJ, Heckmann JG, Neundorfer B (1998) Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 160(2):128-139
19. NNIS System (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. AJIC 32(8):470-485
20. Srinivasan A, Burtin EC, Kuehnert MJ, Rupprecht C, Sutker W, Ksiazek TG, Paddock CD, Guarner J, Shieh WJ, Goldsmith C, Hanlon CA, Zoretic J Fischbach B, Niezgoda M, El-Feky WH, Orciari L, Sanchez EQ, Likos A, Klintmalm GB, Cardo D, Leduc J, Chamberland ME, Jernigan DB, Zaki SR (2005) Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 352:1103-1111
21. Strom BL, Tugwell P (1990) Pharmacoepidemiology: Current status, prospects, and problems. Ann Intern Med 113:179-181
22. United States Census Bureau (2004) Statistical Abstract of the United States: 2004-2005. U.S. Census Bureau, Statistical Abstract of the United States: 2004-2005 (124th Edition) Washington, DC, 2004; page 114. http://www.census.gov/prod/2004pubs/04statab/health.pdf